were obtained during gynaecological operations by biopsy or as a result of oophorectomy from 19 women aged 19-44 years. The tissue was frozen in a programmable freezer using one of two different cryoprotectants, either 1.5 M dimethylsulphoxide (DMSO), or a combination of 1,2-propanediol (1.5 M) and sucrose (0.1 M). After cryopreservation lasting from 24 h to 5 weeks, the ovarian pieces were thawed and studied histologically. Specimens taken before and after cryopreservation with either protectant showed no signs of tissue necrosis. Follicles at similar developmental stages were found before and after freezing. The proportions of follicles showing signs of atresia, 27% in the non-frozen tissue and 19% in the frozenthawed tissue, were not significantly different. Oocytes, too, had the same appearance after freezing and thawing with both cryoprotectants as was seen in the specimens taken before freezing. These results suggest that cryopreservation of human ovarian tissue is feasible. However, the normality of the oocytes taken from tissue which has been frozen still needs to be established. Cryopreservation of ovarian tissue would be potentially an excellent method for storage of human oocytes once methods for their maturation in vitro have been developed.
Introduction
Cryopreservation of oocytes could benefit many infertile patients. Cryopreservation of ovarian tissue before radiotherapy or chemotherapy might allow later replantation of ovarian cortex and restoration of fertility after cancer treatment in young women. If maturation of oocytes in vitro from thawed cryopreserved tissue were possible, many of the problems which limit the usefulness of egg donation would also be solved. Once techniques for in-vitro maturation of follicles and eggs have been developed and are reliable, frozen storage 1268 of ovarian tissue could revolutionize treatment by in-vitro fertilization (IVF). Patients would no longer be required to undergo ovulation induction with exogenous gonadotrophins, and the clinical monitoring which makes IVF so demanding for patients would be greatly simplified. IVF would be cheaper and the side-effects from stimulatory drugs avoided.
After replantation of frozen-thawed ovarian grafts, successful pregnancies in mice were reported by Parrott (1960) . In these early experiments grafts were stored at -79°C and glycerol was used as a cryoprotectant. Carroll and Gosden (1993) transplanted isolated mouse primordial follicles after cryopreservation using dimethylsulphoxide (DMSO). The recipient site used was the ovarian bursae, and normal offspring were born. Extra-ovarian maturation of cryopreserved mouse primary follicles had already been successful (Carroll et al., 1990) .
Sheep have been similarly treated. Ovarian tissue slices were preserved in liquid nitrogen after using DMSO as a cryoprotectant (Gosden et ai, 1994a) . These animals became pregnant following transplantation of thawed ovarian tissue. Cryopreserved marmoset ovarian tissue has also been transplanted under the kidney capsule of immunodeficient mice (Candy et al, 1995) . Grafts recovered 21-32 days later contained follicles at all stages of folliculogenesis, including antral follicles 1-2 mm in diameter.
In the present study, human ovarian tissue was cryopreserved using one of two cryoprotectants, DMSO and a combination of 1,2-propanediol and sucrose. The latter is thought to be less toxic than DMSO and has been successfully used in the cryopreservation of human embryos (Lassalle et al., 1985) .
Materials and methods
Ovarian tissue was obtained during gynaecological operations by biopsy or from total oophorectomy. In all, 19 women, aged 19-44 years (mean 35 years), donated tissue after informed consent
The ovarian tissue was placed in a-minimum essential medium (a-MEM; Gibco, Life Technologies Ltd, Paisley, Scotland) and 10% human serum in the operating theatre and transferred to the laboratory within a few minutes. The ovarian tissue was cut into pieces (0.3-2 mm in diameter) using a scalpel blade and needles and placed in an incubator in 5% CO2 in air at 37°C. One or two pieces, depending on the size of the specimen, were immediately fixed in Bouin's solution for subsequent histology.
Freezing (DMSO)
Ovarian tissue from nine patients was frozen using DMSO (Sigma Chemical Company, St. Louis, MO, USA) as cryoprotectant (Gosden et al., 1994a) . After incubation for 30 min, ovarian tissue was transferred to freezing medium containing DMSO (1.5 M DMSO in a-MEM with 10% human serum); this had been pre-cooled to 0°C in an ice bath. The vials (Nunc freezing vials; Nunclon, Roskilde, Denmark) containing the tissue were kept in this medium at 0°C for 5 min until transfer to a programmable freezer (Kryo 10; Planer Biomed, Sunbury on Thames, UK). After -10 min further at 0°C, the vials were cooled at 2°C/min to -7°C. The specimens were held at this temperature for 5 min, and ice crystal formation was induced manually by touching the cryotubes containing the freezing medium with forceps prechilled in liquid nitrogen. After a further 10 min they were cooled at 0.3°C/min to -40°C and then at -10°C/min to -150°C. They were then transferred to liquid nitrogen (-196°C) and stored.
Thawing (DMSO)
The vials were thawed in air at room temperature for 2 min and then immersed in a water bath at 37°C until the ice had thawed. The tissue pieces were then immediately transferred to culture medium. They were washed three times with new medium before further processing.
Freezing (propanediol)
Tissue specimens from 10 patients were frozen using the combination of 1,2-propanediol (Sigma) and sucrose (Sigma) as a cryoprotectant. After incubation, tissue pieces were transferred to medium containing 1.5 M propanediol and 0.1 M sucrose in a-MEM supplemented with 20% human serum at room temperature. After a further 10 min they were transferred to the programmable freezer, at a starting temperature of 18°C. They were cooled at 2°C/min to -8°C. After being held at that temperature for 5 min, ice crystal formation was induced. After a further 10 min they were cooled at -0.3°C/min to -30°C and then at -50°C/min to -150°C. They were then transferred to liquid nitrogen and stored.
Thawing (propanediol)
Vials were taken from the liquid nitrogen, kept in air for 30 s and immersed in a water bath at 30°C. When the ice had thawed, the tissue pieces were immediately transferred to medium containing 1.0 M propanediol and 0.2 M sucrose in a-MEM supplemented with 20% human serum. After 5 min they were transferred to medium containing 0.5 M propanediol and 0.2 M sucrose, and after another 5 min to medium with 0.2 M sucrose, where they were kept for 10 min. They were then transferred to medium containing 20% serum and kept in this for 10 min at room temperature. Further processing was in fresh medium in an incubator.
Once thawed, the tissue pieces were fixed in Bouin's solution. Both frozen-thawed tissue and control tissue were embedded in paraffin and cut into 2 u\m sections, which were then stained with haematoxylin and eosin. The primordial, primary, secondary and tertiary follicles were classified as described by Gougeon (1986) and counted per high power field (HPF) using a Zeiss Standard microscope and X400 magnification. The proportions of morphologically normal follicles before and after freezing were counted. Eosinophilia of the ooplasm, contraction and clumping of the chromatin material and wrinkling of the nuclear membrane of the oocytes were regarded as signs of atresia (Gougeon, 1986) . The % 2 test and Student's /-test were used for the statistical comparisons.
Results
There was no identifiable difference in histological examination of ovarian tissue before and after freezing. This was irrespective of the cryoprotectant used. There were no light microscopical changes in the tissue components. Central necrosis was not seen, even in pieces as large as 2 mm in diameter. Follicles at varying developmental stages were found similarly before and after freezing (Table I ). In non-frozen pieces, 27% of the follicles showed signs of atresia, whereas 19% of the follicles Figure 4 . Primordial follicles in ovarian tissue cryopreserved using propanediol and sucrose. The tissue is from the same patient as that in Figure 3 . Original magnification X400. in frozen-thawed specimens were atretic. This difference was not significant. Oocytes with similar morphology were seen in the follicles before freezing (Figures 1 and 3 ), after freezing with DMSO ( Figure 2 ) and after freezing with propanediol and sucrose (Figure 4) . Table I shows the numbers of primordial and primary follicles per HPF in the sections studied. The ovarian tissue of 10 patients fixed before propanediol freezing contained on average 7.75 primordial and primary follicles/HPF. The corresponding number after cryopreservation was 6.48. In the samples taken before DMSO freezing, a mean of 8.62 primordial and primary follicles/HPF was seen, and after cryopreservation 7.72/HPF. In one biopsy taken from a 40 year old woman, no follicles were found 1 . After freezing and thawing in DMSO, however, one follicle was discovered. The majority of the follicles seen in these biopsy specimens were primordial. Primary follicles were found less frequently, and secondary and tertiary follicles were seen only occasionally. The mean diameters of the follicles and oocytes are shown in Table II . There were no significant differences between the groups.
Discussion
The normal appearance of oocytes and follicles after an attempt at freezing and thawing suggests that human ovarian tissue can be cryopreserved. Consequently, oocytes should be capable of being matured later either naturally after replantation, or by maturation in vitro at the time this becomes technically feasible. Our findings are reassuring. Previously, in cryopreserved marmoset ovaries (Candy et aL, 1995) , vacuoles were described in the cytoplasm of the oocyte. There was no vacuolation of thawed material in the oocytes in our present study. This could be due to species difference or because of slight differences in the freezing protocols. No differences were seen in the size of oocytes or follicles before and after freezing; this finding is similar to that of Gougeon (1986) .
To assess whether primordial and primary follicles retain their developmental ability, ovarian biopsies have been transplanted under the kidney capsule of severe combined immunodeficiency mice. Gosden et aL (1994b) showed the feasibility of this with biopsies taken from cats and sheep, and Candy et aL (1995) did similar work with the marmoset. This approach is now needed to assess the functional viability of cryopreserved human ovarian tissue.
Replantation of cryopreserved ovarian tissue slices after radiotherapy or chemotherapy should offer the possibility of success, as has been the case in sheep (Gosden et aL, 1994a) . This would probably not give long-lasting fertility, but biopsies could be replanted at laparoscopy without great technical difficulty. Presumably, such a procedure could be repeated several times, giving an added chance of repeated pregnancy.
An alternative to freezing of ovarian tissue is oocyte cryopreservation. This has been done successfully in the mouse and live young were born (Whittingham, 1977) . Live young have also resulted from rabbit (Al-Hasani et aL, 1989) , cow (Fuku et aL, 1992) and human frozen oocytes (Chen, 1986) . However, success in freezing mature oocytes has been limited. Fertilization rates of human oocytes after using either propanediol or DMSO have been reasonable (75 and 50% respectively), but polyploidy has been very common (Al Hasani et aL, 1987; Mandelbaum et al., 1988) . Both cooling and DMSO have adverse effects on the microtubular system of mice oocytes Pickering and Johnson, 1987) . In human oocytes the structure of the filaments is thought to make them more susceptible to damage of the meiotic spindle with a risk of aneuploidy (Pickering et al., 1988) . The meiotic spindle of human oocytes has also been shown to be sensitive to cooling (Sathananthan et al., 1988) . Increased polyploidy was reported in mouse embryos derived from frozen-thawed oocytes (Glenister et al., 1987; Carroll et al., 1989; Trounson and Kirby, 1989; Bouquet et aL, 1992) , and this was thought to be due to an increased risk of digyny after retention of the second polar body.
For all these reasons, freezing of ovarian tissue containing immature oocytes may be a technology worthy of exploration. Cryopreservation of the oocytes at an immature stage has been suggested to overcome spindle damage, and there has been greater success (Mandelbaum et al, 1988) . Human prophase I oocytes from an FVF programme have been frozen using propanediol (Toth et al, 1994) . These oocytes showed an 83% rate of maturation and a 58% rate of fertilization after thawing.
In the mouse, cryopreservation of immature oocytes and invitro maturation after thawing have reportedly been successful. However, the developmental capacity was lower than that of fresh oocytes matured in vitro (Schroeder et al, 1990) . In a recent report (Candy et al, 1995) , the overall survival of mouse oocytes frozen at the germinal vesicle stage compared favourably with the estimated overall survival rate of oocytes. Candy et al. (1995) explained the increased post-implantation loss as due to suboptimal conditions of maturation in vitro rather than freezing injury. Cryopreservation of immature human oocytes could be possible as well, and, in particular, cryopreservation of very small oocytes in primordial and primary follicles might save the cells from spindle damage.
Although DMSO has been shown to have toxic effects at temperatures >4°C and is possibly genotoxic, other cryoprotectants, such as propanediol with sucrose, look promising (Lassalle et al, 1985; Shaw etal, 1995) . However, propanediol has not been used for cryopreservation of ovarian tissue. Our results show that propanediol with sucrose is as good a cryoprotectant as DMSO.
Although it has been possible to mature viable oocytes from frozen primary follicles in the mouse (Carroll et al, 1990) , until recently it has not been possible to mature human oocytes from primordial, primary or pre-antral follicles (Roy and Treacy, 1993; Eppig, 1994; Nayudu, 1994; Spears, 1994) . The dense nature of human ovarian tissue has made preparation of follicles extremely difficult. A recent advance has been made by Abir et al (1995) . They matured pre-antral follicles, of 100-400 (im diameter, in vitro after harvesting them mechanically from human ovarian tissue. Antral follicles of up to 1.6 mm in diameter developed in vitro. The method is time-consuming and ovarian biopsies contain rather few preantral follicles. However, this technique should be worth further research.
If follicles can be cultured to antral stages, it might be possible to remove the cumulus-enclosed oocytes and develop them in a secondary culture system. In-vitro maturation of human germinal vesicle-stage oocytes has already been successful and children have been born (Cha et al., 1991; Trounson et al, 1994) ; further improvements are likely.
Human fetal ovarian tissue has been cryopreserved by an ultra-rapid freezing method after DMSO treatment by Zhang et al. (1995) . They described follicular development afterwards, but fertilization was not attempted. The results of freezing were not as good as in our study, central necrosis of the tissue pieces occurring. The results with fetal ovarian tissue are probably not comparable with those obtained with adult tissue, and clinical use of fetal ovarian tissue raises huge ethical problems.
We consider that if our work is to have clinical applications, several biopsies will be needed to be cryopreserved. This is because we have found fewer primordial, primary or larger follicles than we expected. Moreover, in the human their distribution seems erratic.
The present study shows that cryopreservation of ovarian tissue is not a major problem. However, much effort will have to be devoted to the maturation of small follicles in vitro, before the potential of cryopreservation of ovarian tissue can be fully realized.
